SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms

There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. Here, the authors perform a prospective observational household study and find that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms.

Guardado en:
Detalles Bibliográficos
Autores principales: Janeri Fröberg, Joshua Gillard, Ria Philipsen, Kjerstin Lanke, Joyce Rust, Diana van Tuijl, Karina Teelen, Teun Bousema, Elles Simonetti, Christa E. van der Gaast-de Jongh, Mariska Bos, Frank J. van Kuppeveld, Berend-Jan Bosch, Marrigje Nabuurs-Franssen, Nannet van der Geest-Blankert, Charlotte van Daal, Martijn A. Huynen, Marien I. de Jonge, Dimitri A. Diavatopoulos
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/50f02a2039984e818d1c4dc6db699767
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:50f02a2039984e818d1c4dc6db699767
record_format dspace
spelling oai:doaj.org-article:50f02a2039984e818d1c4dc6db6997672021-12-02T18:14:31ZSARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms10.1038/s41467-021-25949-x2041-1723https://doaj.org/article/50f02a2039984e818d1c4dc6db6997672021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25949-xhttps://doaj.org/toc/2041-1723There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. Here, the authors perform a prospective observational household study and find that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms.Janeri FröbergJoshua GillardRia PhilipsenKjerstin LankeJoyce RustDiana van TuijlKarina TeelenTeun BousemaElles SimonettiChrista E. van der Gaast-de JonghMariska BosFrank J. van KuppeveldBerend-Jan BoschMarrigje Nabuurs-FranssenNannet van der Geest-BlankertCharlotte van DaalMartijn A. HuynenMarien I. de JongeDimitri A. DiavatopoulosNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Janeri Fröberg
Joshua Gillard
Ria Philipsen
Kjerstin Lanke
Joyce Rust
Diana van Tuijl
Karina Teelen
Teun Bousema
Elles Simonetti
Christa E. van der Gaast-de Jongh
Mariska Bos
Frank J. van Kuppeveld
Berend-Jan Bosch
Marrigje Nabuurs-Franssen
Nannet van der Geest-Blankert
Charlotte van Daal
Martijn A. Huynen
Marien I. de Jonge
Dimitri A. Diavatopoulos
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
description There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. Here, the authors perform a prospective observational household study and find that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms.
format article
author Janeri Fröberg
Joshua Gillard
Ria Philipsen
Kjerstin Lanke
Joyce Rust
Diana van Tuijl
Karina Teelen
Teun Bousema
Elles Simonetti
Christa E. van der Gaast-de Jongh
Mariska Bos
Frank J. van Kuppeveld
Berend-Jan Bosch
Marrigje Nabuurs-Franssen
Nannet van der Geest-Blankert
Charlotte van Daal
Martijn A. Huynen
Marien I. de Jonge
Dimitri A. Diavatopoulos
author_facet Janeri Fröberg
Joshua Gillard
Ria Philipsen
Kjerstin Lanke
Joyce Rust
Diana van Tuijl
Karina Teelen
Teun Bousema
Elles Simonetti
Christa E. van der Gaast-de Jongh
Mariska Bos
Frank J. van Kuppeveld
Berend-Jan Bosch
Marrigje Nabuurs-Franssen
Nannet van der Geest-Blankert
Charlotte van Daal
Martijn A. Huynen
Marien I. de Jonge
Dimitri A. Diavatopoulos
author_sort Janeri Fröberg
title SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
title_short SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
title_full SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
title_fullStr SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
title_full_unstemmed SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
title_sort sars-cov-2 mucosal antibody development and persistence and their relation to viral load and covid-19 symptoms
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/50f02a2039984e818d1c4dc6db699767
work_keys_str_mv AT janerifroberg sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT joshuagillard sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT riaphilipsen sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT kjerstinlanke sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT joycerust sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT dianavantuijl sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT karinateelen sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT teunbousema sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT ellessimonetti sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT christaevandergaastdejongh sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT mariskabos sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT frankjvankuppeveld sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT berendjanbosch sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT marrigjenabuursfranssen sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT nannetvandergeestblankert sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT charlottevandaal sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT martijnahuynen sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT marienidejonge sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
AT dimitriadiavatopoulos sarscov2mucosalantibodydevelopmentandpersistenceandtheirrelationtoviralloadandcovid19symptoms
_version_ 1718378392891424768